Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline
New AI-enhanced solution helps identify promising drug formulations, compressing early clinical decision-making for new treatments NOTTINGHAM, England, Oct. 2, 2026 /PRNewswire/ -- Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing...